American Vanguard CORP 8-K filings

Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.

NYSE
American Vanguard Corporation reported the voting results from its 2026 Annual Meeting of Stockholders, confirming director elections and the ratification of key proposals.
NYSE
Three directors will not stand for re-election as American Vanguard reduces its board size per a recent credit agreement.
NYSE
American Vanguard Corporation's subsidiary, AMVAC Chemical, secured $285 million in new first and second lien term loans to refinance existing debt and fund general corporate purposes.
NYSE
American Vanguard Corporation reported significantly improved third-quarter financial results, with Adjusted EBITDA increasing over 350% year-over-year, while maintaining its full-year 2025 EBITDA guidance.
NYSE
American Vanguard Corporation has amended its senior credit facility, extending the maturity date but accepting reduced borrowing capacity and stricter financial covenants.
NYSE
American Vanguard Corporation announced significant operational improvements in Q2 2025, with adjusted EBITDA nearly doubling and gross profit margin increasing, while reiterating its full-year revenue and EBITDA guidance.
NYSE
American Vanguard Corporation announced that its stockholders overwhelmingly approved all three proposals at the 2025 Annual Meeting, including the re-election of nine directors, the ratification of Deloitte & Touche LLP as independent auditors, and the advisory approval of executive compensation.
NYSE
American Vanguard Corporation announced it has regained compliance with NYSE listing standards following delayed filings, while reporting a weaker first quarter driven by continued destocking and competitive pressures, offset by significant cost reductions and improved working capital.
NYSE
American Vanguard Corporation announced significantly reduced first quarter 2025 financial results, including a net loss and sharp declines in sales and Adjusted EBITDA, while highlighting substantial progress in cost reduction and working capital management.
NYSE
American Vanguard Corporation's subsidiary, AMVAC Chemical Corporation, amended its loan agreement with BMO Bank, receiving a waiver for a financial reporting delay and adjusting its borrowing capacity.
NYSE
American Vanguard Corporation and its former CEO, Eric Wintemute, have entered into a Cooperation Agreement, resolving a potential board nomination contest.
NYSE
American Vanguard Corporation received a notice from the NYSE regarding noncompliance with listing standards due to a delay in filing its annual report, and has amended its credit facility to extend the deadline for providing audited financial statements.
NYSE
American Vanguard Corporation's subsidiary, AMVAC Chemical Corporation, amended its loan agreement with lenders, modifying financial covenants, reducing borrowing capacity, and introducing restrictions on certain corporate actions.
NYSE
American Vanguard announces preliminary financial results for Q4 and full year 2024, achieving its full-year adjusted EBITDA target and reducing debt and inventory.
NYSE
American Vanguard Corporation announces the retirement of Debra Edwards from its board of directors and the appointment of Carmen Tiu to fill the vacancy.
NYSE
American Vanguard Corporation has appointed Douglas A. Kaye III as its new Chief Executive Officer, effective December 9, 2024, to lead the company's transformation and growth initiatives.
NYSE
American Vanguard reported a challenging third quarter with decreased sales and adjusted EBITDA, but maintained its full-year adjusted EBITDA guidance and highlighted progress in its business transformation.
NYSE
American Vanguard Corporation has approved a compensation plan for its interim leadership team and voluntarily withdrawn registrations for its Dacthal herbicide products following an EPA suspension.
NYSE
American Vanguard reported a slight decrease in quarterly sales and a significant drop in profitability, prompting immediate actions to enhance liquidity and improve cost structure.
NYSE
American Vanguard Corporation's CEO, Eric Wintemute, has stepped down, and an Office of the CEO has been formed to lead the company through a period of transformation.
NYSE
American Vanguard Corporation's CEO, Eric G. Wintemute, has announced his retirement, with a transition agreement in place to ensure a smooth handover.
NYSE
American Vanguard Corporation successfully elected nine directors, ratified its accounting firm, and approved executive compensation policies at its 2024 annual meeting.
NYSE
American Vanguard Corporation announced a strong first quarter in 2024, with significant increases in adjusted EBITDA and operating income.
NYSE
American Vanguard Corporation announced its fourth quarter and full year 2023 financial results, highlighting a significant rebound in Q4 and setting a target for a $15 million adjusted EBITDA gain through a business transformation initiative.
NYSE
American Vanguard Corporation has announced the retirement of a long-standing board member, the appointment of his successor, the adoption of a new severance plan for senior executives, and the declaration of a quarterly cash dividend.
NYSE
American Vanguard Corporation reports it is on track to meet its 2023 financial targets and reaffirms its 2024 outlook, while also detailing ongoing transformation initiatives.